What is ADMA Biologics's finished goods?

ADMA Biologics (ADMA) reported finished goods of $65.29M in Q1 2026.

How has ADMA Biologics's finished goods changed year-over-year?

ADMA Biologics's finished goods increased by 40.1% year-over-year, from $46.59M to $65.29M.

What is the long-term trend for ADMA Biologics's finished goods?

Over 5 years (2020 to 2025), ADMA Biologics's finished goods has grown at a 22.1% compound annual growth rate (CAGR), from $19.2M to $52.06M.

What does finished goods mean?

Completed products ready for sale, valued at the lower of cost or net realizable value.

ADMA Biologics ADMA Finished goods

Finished goods at other companies

HaemoneticsHAE

$189.37M-16.0%

Aurinia PharmaceuticalsAUPH

$4.33M+17.8%

Bio-Rad LaboratoriesBIO

——

AmgenAMGN

——

DanaherDHR

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's finished goods?: ADMA Biologics (ADMA) reported finished goods of $65.29M in Q1 2026.
How has ADMA Biologics's finished goods changed year-over-year?: ADMA Biologics's finished goods increased by 40.1% year-over-year, from $46.59M to $65.29M.
What is the long-term trend for ADMA Biologics's finished goods?: Over 5 years (2020 to 2025), ADMA Biologics's finished goods has grown at a 22.1% compound annual growth rate (CAGR), from $19.2M to $52.06M.
What does finished goods mean?: Completed products ready for sale, valued at the lower of cost or net realizable value.